Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma
Clinical trial NCT01245556 · COMPLETED
Trial details
- NCT number
- NCT01245556
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-11-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.